Maintaining hemodialysis grafts remains a difficult problem. Before the early 1990s, graft declotting was usually performed in the surgical suite. Percutaneous declotting has been evolving since the mid-1980s.
View Article and Find Full Text PDFJ Vasc Interv Radiol
November 2000
Purpose: Reteplase, a truncated mutant of tissue plasminogen activator, has been used successfully in the treatment of acute coronary occlusion, but, heretofore, it has not been investigated in the setting of peripheral vascular occlusion. Reteplase is a potential recombinant thrombolytic agent that may offer an appropriate alternative to currently employed plasminogen activators.
Materials And Methods: Over a 6-month period reteplase was used to treat peripheral vascular occlusions at five centers in the United States.
AJR Am J Roentgenol
November 1991